Cargando…

Improving (131)I Radioiodine Therapy By Hybrid Polymer-Grafted Gold Nanoparticles

BACKGROUND: Human trials combining external radiotherapy (RT) and metallic nanoparticles are currently underway in cancer patients. For internal RT, in which a radioisotope such as radioiodine is systemically administered into patients, there is also a need for enhancing treatment efficacy, decreasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Goas, Marine, Paquet, Marie, Paquirissamy, Aurélie, Guglielmi, Julien, Compin, Cathy, Thariat, Juliette, Vassaux, Georges, Geertsen, Valérie, Humbert, Olivier, Renault, Jean-Philippe, Carrot, Géraldine, Pourcher, Thierry, Cambien, Béatrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6777639/ https://www.ncbi.nlm.nih.gov/pubmed/31686819 http://dx.doi.org/10.2147/IJN.S211496

Ejemplares similares

Proteomic Analysis of Iodinated Contrast Agent-Induced Perturbation of Thyroid Iodide Uptake
por: Hichri, Maha, et al.
Publicado: (2020)

Normalisation to Blood Activity Is Required for the Accurate Quantification of Na/I Symporter Ectopic Expression by SPECT/CT in Individual Subjects
por: Richard-Fiardo, Peggy, et al.
Publicado: (2012)

(99m)TcO(4) (−)-, Auger-Mediated Thyroid Stunning: Dosimetric Requirements and Associated Molecular Events
por: Cambien, Béatrice, et al.
Publicado: (2014)

Focus on radioiodine-131 biokinetics: the influence of methylprednisolone on intratherapeutic effective half-life of (131)I during radioiodine therapy of Graves’ disease
por: Happel, C., et al.
Publicado: (2021)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

Effects of drugs on the efficacy of radioiodine ((131)|) therapy in hyperthyroid patients
por: Oszukowska, Lidia, et al.
Publicado: (2010)

The influence of thionamides on intra-thyroidal uptake of (131)I during radioiodine-131 treatment of Graves’ disease
por: Happel, Christian, et al.
Publicado: (2023)

A mathematical model of optimized radioiodine-131 therapy of Graves' hyperthyroidism
por: Doi, Suhail AR, et al.
Publicado: (2001)

Treatment failure in hyperthyroid cats after radioiodine (I‐131) injection
por: Mullowney, Deirdre, et al.
Publicado: (2021)

Apoptosis gene reprograming of human peripheral blood mononuclear cells induced by radioiodine-131 ((131)I) irradiation
por: Li, Jian-Fang, et al.
Publicado: (2019)

Primary autoimmune thrombocytopenia and co-existing Graves’ disease: Role of radioiodine-131
por: Jung, Rayamajhi Sampanna, et al.
Publicado: (2014)

Radiosensitive effect of curcumin on thyroid cancer cell death induced by radioiodine-131
por: Hosseinimehr, Seyed Jalal, et al.
Publicado: (2014)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

Identification of oncolytic vaccinia restriction factors in canine high-grade mammary tumor cells using single-cell transcriptomics
por: Cambien, Béatrice, et al.
Publicado: (2020)

Disorders of Dental Hard Tissues Induced by Radioiodine-131 (I-131) Therapy Used in Differentiated Thyroid Cancer: An In Vitro Study
por: Mester, Alexandru, et al.
Publicado: (2020)

Adverse Reactions to Radioiodine 131I Therapy of Goiter in West African Tertiary Hospital
por: Onimode, Yetunde A., et al.
Publicado: (2016)

Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Zhang, Ruiguo, et al.
Publicado: (2017)

Predictors of euthyreosis in hyperthyroid patients treated with radioiodine (131)I(−): a retrospective study
por: Stachura, Albert, et al.
Publicado: (2020)

The Side Effects of Therapeutic Radioiodine-131 on the Structure of Enamel and Dentin in Permanent Human Teeth
por: Mester, Alexandru, et al.
Publicado: (2021)

Radioiodination of Modified Porous Silica Nanoparticles as a Potential Candidate of Iodine-131 Drugs Vehicle
por: Prihatiningsih, Maria Christina, et al.
Publicado: (2022)

Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer
por: Gao, Haiyan, et al.
Publicado: (2023)

The false-positive radioiodine I-131 uptake in the foreign body granuloma located in gluteal adipose tissue
por: Gültekin, Salih Sinan, et al.
Publicado: (2011)

Radioiodine Accumulation in a Giant Ovarian Cystadenofibroma Detected Incidentally by 131-I Whole Body Scans
por: Mebarki, Mohammed, et al.
Publicado: (2012)

Radioiodine ((131)I) therapy in a child with autism spectrum disorder: A complex and demanding task
por: Bibbo, Giovanni, et al.
Publicado: (2019)

Radioiodine Contamination Artifacts and Unusual Patterns of Accumulation in Whole-body I-131 Imaging: A Case Series
por: Ozcan Kara, Pelin, et al.
Publicado: (2014)

Autonomous Functioning Thyroid Nodule in a 4-year-old Male Child Treated with Radioiodine (I-131)
por: Khare, Abhishek, et al.
Publicado: (2013)

Radioiodine-131 Therapy Used for Differentiated Thyroid Cancer Can Impair Titanium Dental Implants: An In Vitro Analysis
por: Piciu, Doina, et al.
Publicado: (2023)

Development of [(131)I]I-EOE-TPZ and [(131)I]I-EOE-TPZMO: Novel Tirapazamine (TPZ)-Based Radioiodinated Pharmaceuticals for Application in Theranostic Management of Hypoxia
por: Elsaidi, Hassan, et al.
Publicado: (2019)

Tumor microenvironment affects exogenous sodium/iodide symporter expression
por: Castillo-Rivera, Fabio, et al.
Publicado: (2020)

Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010)

Ultrasonography Echotexture as a surrogate for Sialadenitis secondary to 131I Radioiodine Therapy for differentiated Thyroid Cancer: a review and metaanalysis
por: Lima, Graziele Aparecida Simões, et al.
Publicado: (2020)

Thyroid Cancer after Exposure to Radioiodine in Childhood and Adolescence: (131)I-Related Risk and the Role of Selected Host and Environmental Factors
por: Zupunski, Ljubica, et al.
Publicado: (2019)

MON-443 SPECT/CT Localization of Incidental Diverticular Bleed After Radioiodine (i(131)) Therapy for Metastatic Thyroid Cancer
por: Doshi, Sejal B, et al.
Publicado: (2020)

The influence of thyroid hormone medication on intra-therapeutic half-life of (131)I during radioiodine therapy of solitary toxic thyroid nodules
por: Happel, Christian, et al.
Publicado: (2022)

Do radioiodine-avid lymph nodes from differentiated thyroid cancer on the initial posttherapy scan need repeated (131)I therapy?
por: Jiang, Yongji, et al.
Publicado: (2023)

Nontoxic Goiter (NTG) and Radioiodine: What Do Patients Think About It? Quality of Life in Patients with NTG Before and After 131-I Therapy
por: Kaniuka-Jakubowska, Sonia, et al.
Publicado: (2018)

A phase I study of pazopanib in combination with escalating doses of (131)I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine
por: Chow, Laura Q., et al.
Publicado: (2017)

Role of single photon emission computed tomography/computed tomography in diagnostic iodine-131 scintigraphy before initial radioiodine ablation in differentiated thyroid cancer
por: Agrawal, Kanhaiyalal, et al.
Publicado: (2015)

Strong Neck Accumulation of (131)I Is a Predictor of Incomplete Low-Dose Radioiodine Remnant Ablation Using Recombinant Human Thyroid-Stimulating Hormone
por: Enomoto, Keisuke, et al.
Publicado: (2015)

Biokinetic model of radioiodine I-131 in nine thyroid cancer patients subjected to in-vivo gamma camera scanning: A simplified five-compartmental model
por: Huang, Chao-Chun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_69hr859keolm8sjuur6g34247o